ALEVE PM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aleve Pm, and what generic alternatives are available?
Aleve Pm is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in ALEVE PM is diphenhydramine hydrochloride; naproxen sodium. There are twenty-three drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride; naproxen sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALEVE PM?
- What are the global sales for ALEVE PM?
- What is Average Wholesale Price for ALEVE PM?
Summary for ALEVE PM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 2 |
| What excipients (inactive ingredients) are in ALEVE PM? | ALEVE PM excipients list |
| DailyMed Link: | ALEVE PM at DailyMed |
Pharmacology for ALEVE PM
| Drug Class | Histamine-1 Receptor Antagonist Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for ALEVE PM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | ALEVE PM | diphenhydramine hydrochloride; naproxen sodium | TABLET;ORAL | 205352-001 | Jan 17, 2014 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
